However, PARP (a functional gene in the NHEJ pathway)85 inhibitors causes SL in BRCA-mutated cancers (Fig. 3biii).36 Further research of the HR pathway revealed that the microhomology-mediated end-joining (MMEJ) pathway also have synthetic lethal interactions with it. Here, PARP1 is linked to cancer.